Mitsubishi Pharma Corp.

News & Analysis

mitsubishi pharma corp. - All News and Analysis

• New Report Assesses Mitsubishi Pharma's Prospects to 2011.

  - 2007-04-20

  M2 PRESSWIRE-20 April 2007-Research and Markets: New Report Assesses Mitsubishi Pharma's Prospects to 2011C1994-2007 M2 COMMUNICATIONS LTD RDATE:24042007 Research and Markets (http://www.researchandmarkets.com/reports/c54762) has announced the addition of Espicom Business Intelligence's new report: Mitsubishi Pharma Prospects to 2011 to their...

  Tags: Mitsubishi Pharma Corp.

• 35 Deals Made by Mitsubishi Pharma Corporation and Its Subsidiaries with 40 Partnering Companies between 2000 and 2005

  - 2005-10-26

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26244) has announced the addition of Mitsubishi Pharma Corporation Deals Briefing to their offering. Mitsubishi Pharma Corporation Deals briefing provides an in-depth view of the 35 deals made by Mitsubishi Pharma Corporation and its subsidiaries with 40 partnering companies between 2000 and 2005,...

  Tags: Mitsubishi Pharma Corp.

• Crucell/Dsm Sign Licensing Pact With Mitsubishi Pharma

  - 2005-05-01

  Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) has announced that allied contract manufacturer DSM Biologics has signed a PER.C6 research license agreement with the Japanese pharmaceutical company Mitsubishi Pharma Corporation. This license agreement allows Mitsubishi to use the PER.C6 cell line for production of certain recombinant therapeutic proteins. This...

  Tags: Crucell N.V., DSM Biologics, Mitsubishi Pharma Corp.

• MediciNova, Inc. Acquires Phase II Anxiety Compound from Mitsubishi Pharma Corporation; Specialty Pharmaceutical Company Expands Product Portfolio

  - 2004-06-10

  Business Editors/Health/Medical Writers

  Tags: Mitsubishi Pharma Corp., Medicinova Inc.

• Dynogen enters into irritable bowel syndrome agreement with Mitsubishi.(Dynogen Pharmaceuticals Inc., Mitsubishi Pharma Corp.)

  - 2003-12-01

  Demonstrating rapid progress in building its clinical pipeline, Dynogen Pharmaceuticals, Inc. (Boston, MA) has entered into a Technology Transfer and License agreement with Mitsubishi Pharma Corporation involving a neurological compound that Dynogen will develop for the treatment of irritable bowel syndrome IBS. The compound, DDP-225...

  Tags: Inc., Mitsubishi Corp., Mitsubishi Pharma Corp.

• Mitsubishi Pharma Corp. to Cut 1,200 Jobs over Three Years.

  - 2003-11-05

  Kyodo News International, Tokyo Knight Ridder/Tribune Business News Nov. 5--OSAKA, Japan--Mitsubishi Pharma Corp. said Wednesday it will cut 1,200 jobs at the parent firm under a new three-year business plan through March 31, 2007. The pharmaceutical firm said it will...

  Tags: Mitsubishi Pharma Corp.

• Mitsubishi Pharma Corp. Sees Net Profit Drop 33.5 Percent in First Half.

  - 2003-11-05

  Kyodo News International, Tokyo Knight Ridder/Tribune Business News Nov. 5--TOKYO--Mitsubishi Pharma Corp. said Wednesday its group net profit for the six months to Sept. 30 fell 33.5 percent from a year earlier to 3.02 billion yen, with revenues down 15.4 percent to 117.21...

  Tags: Mitsubishi Pharma Corp.

• LEAD: Mitsubishi Pharma net profit down 8.1% over reform costs.

  - 2003-05-13

  TOKYO, May 12 Kyodo (EDS: ADDING INFO AT LAST 2 PARAS) Mitsubishi Pharma Corp. said Monday its group net profit for the year ended March 31 fell 8.1% to 8.26 billion yen due to an extraordinary loss connected mainly to structural reform costs...

  Tags: Mitsubishi Pharma Corp.

• Gene Logic adds Mitsubishi Pharma Corp. as customer

  - 2002-09-05

  Gene Logic Inc., a Gaithersburg-based genomics information and bioinformatics company, yesterday picked up Mitsubishi Pharma Corp., a global pharmaceutical company headquartered in Japan, as a customer. Mitsubishi has subscribed to Gene Logic's BioExpress database for use in its drug discovery efforts. Financial terms of the multi-year subscription agreement were not...

  Tags: Mitsubishi Corp., Mitsubishi Pharma Corp.

• Mitsubishi Pharma triples group net profit.

  - 2002-05-20

  TOKYO, May 13 Kyodo (EDS: ADDING CONTENTS OF THREE-YEAR BUSINESS PLAN) Mitsubishi Pharma Corp., created through the Oct. 1 merger of two drugmakers, said Monday its group net profit soared 229.4% to 8.99 billion yen in the year to March 31 due to...

  Tags: Mitsubishi Pharma Corp.